Share This Article:

Cutaneous Myiasis: Is Lucilia cuprina Safe and Acceptable for Maggot Debridement Therapy?

Abstract Full-Text HTML XML Download Download as PDF (Size:498KB) PP. 79-82
DOI: 10.4236/jcdsa.2012.22018    3,982 Downloads   7,206 Views   Citations

ABSTRACT

Preservation of viable tissue is important in wound management. It is achieved by small, incremental removal of devitalised, necrotic and infected tissues. Maggot debridement therapy (MDT) is used in septic necrotic wounds that fail to respond to conventional modalities. MDT has relied on Lucilia cuprina, which consumes only necrotic tissues, as opposed to Lucilia cuprina, which devours both flesh and necrotic tissues. Recent findings have shown that L. cuprina consumes mainly necrotic and very small amounts of viable tissues and may be used in MDT where L. sericata is very rare or absent. Here we describe wound healing in a patient from rural South Africa with cutaneous myiasis. Our findings agree with workers who indicated that L. cuprina could be used in MDT.

Cite this paper

H. Joesphia Kingu, S. Kamande Kuria, M. Herrer Villet, J. Nthekeleng Mkhize, A. Dhaffala and J. Michael Iisa, "Cutaneous Myiasis: Is Lucilia cuprina Safe and Acceptable for Maggot Debridement Therapy?," Journal of Cosmetics, Dermatological Sciences and Applications, Vol. 2 No. 2, 2012, pp. 79-82. doi: 10.4236/jcdsa.2012.22018.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] F. Zumpt, “Myiasis in Man and Animals in the Old World: A Textbook for Physicians, Veterinarians and Zoologists,” Butterworths, London, 1965.
[2] A. Vilcinskas, “From Traditional Maggot Therapy to Modern Biosurgery,” Insect Biotechnology, Vol. 2, 2011, pp. 67-75.
[3] M. M. Kotb, T. I. Tantawi, Y. M. Gohar, F. M. S. Beshara and S. M. S. Fatthalah, “The Medicinal Use of Maggots in the Management of Venous Stasis Ulcers and Diabetic Foot Ulcers,” Bulletin of the Alexandria Faculty of Medicine, Vol. 37, 2002, pp. 205-214.
[4] A. G. Paul, N. W. Ahmad, H. L. Lee, A. M. Ariff, M. Saranum, A. S. Naicker and Z. Osman, “Maggot Debridement Therapy with Lucilia cuprina: A Comparison with Conventional Debridement in Diabetic Foot Ulcers” International Wound Journal, Vol. 6, No. 1, 2009, pp. 39-46. doi:10.1111/j.1742-481X.2008.00564.x
[5] T. I. Tantawi, Y. M. Gohar, M. M. Kotb, F. M. Beshara and M. M. El-Naggar, “Clinical and Microbiological Efficacy of Mdt in the Treatment of Diabetic Foot Ulcers,” Journal of Wound Care, Vol. 16, No. 9, 2007, pp. 379-383.
[6] T. I. Tantawi, K. A. Williams and M. H. Villet, “An Accidental but Safe and Effective Use of Lucilia cuprina (Diptera: Calliphoridae) in Maggot Debridement Therapy in Alexandria, Egypt,” Journal of Medical Entomology, Vol. 47, No. 3, 2010, pp. 491-494. doi:10.1603/ME09183
[7] I. N. Tuygun, A. Taylan-Ozkan, G. Gonül Tanir and K. Y. Mumcuoglu, “Furuncular Myiasis in a Child Caused by Wohlfahrtia magnifica (Diptera: Sarcophagidae) Associated with Eosinophilia,” The Turkish Journal of Pediatrics, Vol. 51, No. 3, 2009, pp. 279-281.
[8] T. A. Szakacs, P. MacPherson, B. J. Sinclair, B. D. Gill and A. E. McCarthy, “Nosocomial Myiasis in a Canadian Intensive Care Unit,” Canadian Medical Association Journal, Vol. 177, No. 7, 2007, pp. 719-720. doi:10.1503/cmaj.061598

  
comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.